THYROCARE TECHNOLOGIES
Back to Balance Sheet
|
THYROCARE TECHNOLOGIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹2.26 Cr | ₹0.62 Cr | ₹1.61 Cr | ₹1.61 Cr | ₹51 Cr |
What is the latest Contingent Liabilities ratio of THYROCARE TECHNOLOGIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹2.26 Cr |
| Mar2024 | ₹0.62 Cr |
| Mar2023 | ₹1.61 Cr |
| Mar2022 | ₹1.61 Cr |
| Mar2021 | ₹51 Cr |
How is Contingent Liabilities of THYROCARE TECHNOLOGIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.26 Cr | 264.52 | |
| Mar2024 | ₹0.62 Cr | -61.49 | |
| Mar2023 | ₹1.61 Cr | 0.00 | |
| Mar2022 | ₹1.61 Cr | -96.83 | |
| Mar2021 | ₹51 Cr | - | |
Compare Contingent Liabilities of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹6,474.7 Cr | -1.8% | -13% | 53.9% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹109,441.0 Cr | 4.5% | 3.7% | 11.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹104,646.0 Cr | 4.3% | 2% | -7.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹69,124.0 Cr | 2.9% | 0.5% | 42.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹37,533.9 Cr | 4.3% | -6.4% | 32.7% | Stock Analytics | |
| GLOBAL HEALTH | ₹30,776.5 Cr | -2.3% | -2.6% | -1.8% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | -1.8% |
-13% |
53.9% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses